Tau Aggregation via R2 Fragment Seeding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing Tau fibrils in vitro fail to replicate the structural and functional characteristics of paired-helical filaments (PHFs) found in Alzheimer's disease brains, limiting the understanding of Tau aggregation and its role in neurodegeneration, and the development of therapeutic agents and diagnostic tools.
Innovation Solution
A method involving R2 fragments that form fibrils in the presence of polyanions, breaking them down into seeds, and contacting Tau proteins with these seeds to induce aggregation, resulting in PHFs-like Tau aggregates, which can be used to identify inhibitors and as imaging agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional methods are used to prepare Tau fibrils in vitro, then the preparation process is simple, but the structural and functional characteristics of native PHFs are not replicated
Solution Approach 1:
The method segments the Tau protein preparation process into distinct stages: first forming fibrils from R2 fragments with polyanions, then breaking them down into seeds, and finally contacting these seeds with full-length Tau proteins to induce aggregation. This segmentation allows each stage to be optimized independently, achieving native PHF characteristics while managing complexity through systematic breakdown of the preparation process.
Solution Approach 2:
The method performs preliminary actions by first preparing R2 fibrils and breaking them into seeds before introducing full-length Tau proteins. This preliminary formation of aggregation-prone structures creates a template that guides the subsequent aggregation of full-length Tau, ensuring the final aggregates replicate native PHF characteristics without requiring complex direct preparation methods.
2Reliability
If R2 fragments are used to form fibrils with polyanions, then PHFs-like Tau aggregates with native characteristics are produced, but the preparation process becomes more complex
Solution Approach 1:
R2 fragments serve as an intermediary substance that mediates between the polyanions and full-length Tau proteins. The R2 fragments first form fibrils with polyanions, then these fibrils are broken into seeds that act as templates for full-length Tau aggregation. This intermediary approach ensures reliable native PHF characteristics while organizing the complexity into manageable sequential steps.
Solution Approach 2:
The method utilizes parameter changes by controlling the physical and chemical conditions at each stage: forming R2 fibrils with specific polyanion concentrations, breaking them into seeds through controlled fragmentation, and then adjusting conditions for full-length Tau aggregation. These parameter changes enable reliable reproduction of native PHF characteristics while systematically managing the complexity of the multi-step process.
3Manufacturing precision
If full-length Tau proteins are directly induced to aggregate, then the process is straightforward, but the resulting aggregates lack native PHF seeding properties
Solution Approach 1:
Instead of directly aggregating full-length Tau proteins, the method performs preliminary actions by first creating R2 fibrils and breaking them into seeds. These pre-formed seeds possess the native PHF characteristics and serve as templates that direct the aggregation of full-length Tau proteins, ensuring the resulting aggregates have proper seeding properties without requiring complex direct aggregation protocols.
Solution Approach 2:
The method uses R2 fibrils as a template or copy of the native PHF structure. By breaking these fibrils into seeds and using them to induce aggregation of full-length Tau proteins, the native PHF structural and functional characteristics are copied into the new aggregates, ensuring they possess authentic seeding properties while simplifying the overall process compared to attempting to directly recreate native structures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method successfully produces Tau aggregates with morphological and seeding properties similar to native PHFs, enabling the identification of inhibitors and the development of diagnostic and therapeutic tools for Alzheimer's disease.
Implementation Method 1
This is most likely driven by charge compensation of the basic part of Tau, whereby the polyanionic compound binds to extended form of the protein, favoring its conversion into β-sheets
Implementation Method 2
Tau contains several short stretches of amino acid that present a high propensity to fold into β-sheets, notably the first 8-10 amino acid of the repeat peptides R2 to R4
Implementation Method 3
breaking them down into seeds
Implementation Method 4
contacting Tau proteins comprising SEQ ID NO: 1 with the R2 fibrils seeds under conditions which allow Tau aggregation
Implementation Method 5
allowing formation of R2 fibrils
Data Source
AI summary
The invention relates to a method for preparing PHFs-like Tau aggregates and to a method for identifying compounds that are inhibitors of Tau protein aggregation, blockers of Tau seeding and propagation, and imaging agents that specifically bind PHF.